BR0109783A - Treatment of kidney disease - Google Patents

Treatment of kidney disease

Info

Publication number
BR0109783A
BR0109783A BR0109783-0A BR0109783A BR0109783A BR 0109783 A BR0109783 A BR 0109783A BR 0109783 A BR0109783 A BR 0109783A BR 0109783 A BR0109783 A BR 0109783A
Authority
BR
Brazil
Prior art keywords
treatment
kidney disease
amlodipine
normotensive
disease
Prior art date
Application number
BR0109783-0A
Other languages
Portuguese (pt)
Inventor
Adrian Paul Foster
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR0109783A publication Critical patent/BR0109783A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"TRATAMENTO DE DOENçAS RENAIS". A invenção aqui descrito refere-se ao uso de bloqueadores dos canais de cálcio tais como a amlodipina no tratamento de uma doença renal em animais normotensivos. Também descritas são novas unidades de dosagem de amlodipina adequadas para o tratamento de uma doença renal em gatos normotensivos."TREATMENT OF RENAL DISEASES". The invention described herein relates to the use of calcium channel blockers such as amlodipine in the treatment of renal disease in normotensive animals. Also described are novel amlodipine dosage units suitable for the treatment of kidney disease in normotensive cats.

BR0109783-0A 2000-04-04 2001-03-28 Treatment of kidney disease BR0109783A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008332.9A GB0008332D0 (en) 2000-04-04 2000-04-04 Treament
PCT/IB2001/000518 WO2001074390A2 (en) 2000-04-04 2001-03-28 The use of a calcium channel blocker for treating renal disorders

Publications (1)

Publication Number Publication Date
BR0109783A true BR0109783A (en) 2003-01-21

Family

ID=9889228

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109783-0A BR0109783A (en) 2000-04-04 2001-03-28 Treatment of kidney disease

Country Status (12)

Country Link
EP (1) EP1284719A2 (en)
JP (1) JP2003528927A (en)
AR (1) AR027763A1 (en)
AU (1) AU2001239510A1 (en)
BR (1) BR0109783A (en)
CA (1) CA2403950A1 (en)
GB (1) GB0008332D0 (en)
MX (1) MXPA02009819A (en)
PA (1) PA8514601A1 (en)
PE (1) PE20011163A1 (en)
TN (1) TNSN01051A1 (en)
WO (1) WO2001074390A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
CZ20031779A3 (en) * 2000-12-29 2004-10-13 Bioorganicsáb@V Process for preparing amlodipine, its derivatives and precursors thereof
AT5874U1 (en) * 2000-12-29 2003-01-27 Bioorg Bv PHARMACEUTICAL PREPARATIONS CONTAINING AMLODIPINMALEAT
RU2311903C2 (en) * 2001-11-07 2007-12-10 Синтон Б.В. Tamzulosin tablets
NL1019882C2 (en) * 2002-02-01 2003-08-04 Synthon Licensing Pharmaceutical tablet composition useful for treating or preventing hypertension, angina or congestive heart failure comprises amlodipine free base
CO5400144A1 (en) * 2002-03-11 2004-05-31 Novartis Ag ORGANIC COMPOUNDS
US7423009B2 (en) 2002-09-30 2008-09-09 Kowa Company, Ltd. Method for treatment of kidney diseases
EP1604664A4 (en) 2003-01-31 2006-12-27 Sankyo Co Medicine for prevention of and treatment for arteriosclerosis and hypertension
WO2006085208A2 (en) * 2005-02-11 2006-08-17 Ranbaxy Laboratories Limited Stable solid dosage forms of amlodipine and benazepril
US10130624B2 (en) 2005-03-15 2018-11-20 Lupin Limited Pharmaceutical compositions of amlodipine and benazepril
BRPI0611024A2 (en) * 2005-04-29 2010-11-09 Hills Pet Nutrition Inc method for extending feline life, for delaying the onset of feline renal failure and for reducing morbidity and mortality from feline kidney disease, kit and means for communicating information or instructions related to the use of a diet having reduced levels of protein, phosphorus and sodium
KR20180123021A (en) * 2016-03-24 2018-11-14 다이이찌 산쿄 가부시키가이샤 Medicines for the treatment of kidney disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
DK0459666T3 (en) * 1990-05-31 1994-12-05 Pfizer Medicines for impotence
NZ242724A (en) * 1991-05-15 1994-09-27 Du Pont Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
CA2124445A1 (en) * 1991-11-26 1993-06-10 James W. Young Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
MX9706957A (en) * 1995-03-16 1997-11-29 Pfizer Composition containing amlodipine, or a salt or felodipine and anace inhibitor.
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
PE20011163A1 (en) 2001-11-12
MXPA02009819A (en) 2003-03-27
PA8514601A1 (en) 2002-08-26
GB0008332D0 (en) 2000-05-24
CA2403950A1 (en) 2001-10-11
AU2001239510A1 (en) 2001-10-15
WO2001074390A2 (en) 2001-10-11
EP1284719A2 (en) 2003-02-26
AR027763A1 (en) 2003-04-09
TNSN01051A1 (en) 2005-11-10
WO2001074390A3 (en) 2002-05-30
JP2003528927A (en) 2003-09-30

Similar Documents

Publication Publication Date Title
BR0109783A (en) Treatment of kidney disease
FIU20060389U0 (en) Treatment of bone diseases
IS2782B (en) Pharmaceutical and cosmetic compositions comprising cod serine proteinases and their pharmaceutical and cosmetic use
BRPI0409791A (en) cannabinoid receptor ligands and their use
DE69734483D1 (en) Polynucleotide vaccine, preferably for the treatment of respiratory disease in cattle
BRPI0409634A (en) cannabinoid receptor ligands and their use
MA26545A1 (en) BONE HEALING PROCESSES
ID23496A (en) PLANT EXTRACT TO TREAT IMPROVEMENT OF BONE RESORTS
CY1111912T1 (en) METHOD OF RESTRICTING OSTEOKLASTS ACTIVITY
BR0113176A (en) Bicyclo-pyrazole compounds, pharmaceutical compositions comprising the compounds, use of the compounds in the manufacture of medicaments, processes for the preparation of the compounds, combinatorial chemical collection and methods for the treatment of mammals including humans using the compounds.
DE60123238D1 (en) COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE60130008D1 (en) PROTEIN COMBINATIONS FOR HEALING WOUNDS
BR0209430B1 (en) heterocyclic compounds, process for their preparation, animal pest control compositions, use of said compounds as well as preparation of said compositions
ATE246708T1 (en) ELATASE INHIBITORS
ID24060A (en) IMPROVED ANIMAL SKIN TREATMENT
DE69737029D1 (en) BIOMEMBRANE FOR SUBSTITUTION, RECONSTRUCTION, INDUCTION OF ANGIOGENESIS, RE-FORMATION OR REGENERATION OF HUMAN OR ANIMAL ORGANS OR TISSUE
ID21369A (en) PHARMACEUTICAL COMPOSITION FOR HEALING OF DISEASES CAUSED BY VIRUS
DE69831223D1 (en) FREEZE-DRIED COMPOSITION OF THE HUMAN, MORPHOGOUS BONE PROTEIN MP52
DE60105053D1 (en) TISSUE TREATMENT COMPOSITIONS
DE60122601D1 (en) Treatment of inflammatory bowel disease
MA25594A1 (en) STIMULATING BONE FACTOR.
DE69704220T2 (en) Synergistic fungicidal mixtures for controlling plant diseases
BR9708648A (en) Il-6 mutein
UY26652A1 (en) TREATMENT OF RENAL DISORDERS
ATE285468T1 (en) TISSUE TREATMENT PREPARATION

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE 6A., 7A., E 8A. ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.